Search

everythinglearnresearchcommunity

for

Search:↓

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

A dissolving microneedle patch with collagen XVII effectively promotes hair regrowth in androgenic alopecia.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

Combining eflornithine cream with laser treatment removes facial hair better than laser alone.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Using enzymes with laser hair removal may reduce unwanted hair growth better than laser alone.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Advanced dermoscopy techniques improve diagnosis and treatment monitoring for Kerion celsi but don't guarantee full hair regrowth.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

CS12192 effectively treats alopecia areata with better safety than current options.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Enemas can cause septicemia in elderly men with prostate infections.

Macrofocused ultrasound is a safe and effective treatment for reducing enlarged facial pores.

Apremilast shows promise for several skin conditions but needs more research.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Rare earth elements are crucial in medical imaging and cancer treatment.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.